Hypera S.A. ( HYPMY) - Stock Earnings
HYPMY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
HYPMY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 82.2 million USD | 407.7 million USD |
| 2026Q1 | 64.9 million USD | 377.0 million USD |
| 2026Q2 | 94.7 million USD | 451.4 million USD |
HYPMY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 339.6 million USD | 1.6 billion USD |
| 2024 | 216.1 million USD | 1.2 billion USD |
| 2025 | 217.8 million USD | 1.4 billion USD |
| 2026 Est. | — | — |
HYPMY
Price: $5.30
Dividend Yield: 4.91%
Forward Dividend Yield: 2.39%
Payout Ratio: 30.43%
Dividend Per Share: 0.13 USD
Earnings Per Share: 0.52 USD
P/E Ratio: 7.92
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Brazil
Market Capitalization: 3.8 billion
Average Dividend Frequency: 5
Years Paying Dividends: 11
DGR3: -8.75%
DGR5: -0.83%